Ona Therapeutics-old

Biotech company located in the Barcelona Science Park (PCB), specializes in the discovery and development of therapeutic biologics targeting tumor metastatic-initiating cells and lipid metabolism.

The company has demonstrated that blocking the pathways that allow fat metabolism in animal models of cancer inhibits the cells that give rise to metastases, with the potential to not only prevent the development of these malignant growths, but also to eliminate existing ones. Founded in 2019, it was a spin-off from ICREA and IRB Barcelona.

INVOLVED TEAM

Clara Campàs, PhD

MANAGING PARTNER & CO-FOUNDER

Anna Bellmunt, PhD

ASSOCIATE